taVNS in Mild to Moderate Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Parkinson Disease
Interventions
DEVICE

Active taVNS

Patients will be masked to transcutaneous stimulation of the auricular branch of the vagus nerve at the tragus

DEVICE

Sham Stimulation

Sham stimulation involves identical perceptual threshold finding and stimulation parameters as active stimulation, with the exception of stimulation target. Sham stimulation will be delivered to the left earlobe, a target believed to have little to no vagal nerve innervation.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT04157621 - taVNS in Mild to Moderate Parkinson's Disease | Biotech Hunter | Biotech Hunter